Comment on “Prognostic value of bioelectrical impedance analysis in heart failure: A systematic review of congestion assessment and clinical outcomes” Authors: Lijiang Li, Bingjun Che Published: 2026 Dear Editor, We read with great interest the systematic review by Rodil Fraile et al. [1], on the prognostic value of bioelectrical impedance analysis (BIA) for congestion assessment in heart failure (HF). Two included studies do not report the clinically relevant outcome the review's own eligibility criteria required The inclusion criterion required reporting of clinically relevant outcomes, such as mortality, HF rehospitalization, or worsening HF events. Yamazoe et al. reported the amount of weight reduction needed to reach a decongestive target, and Massari et al. reported the hospital length of stay; neither is a mortality, rehospitalization, or worsening HF endpoint, and both are more accurately characterized as measures of decongestive treatment intensity or resource utilization. Retaining these two studies within a total count of 13 inflates the apparent size of the prognostic evidence base for congestion-related clinical outcomes, even though the review appropriately excludes both from the Newcastle-Ottawa quality scoring for exactly this reason [2]. A revised count restricted to studies meeting the review's outcome definition would more accurately represent how many independent cohorts actually support the prognostic claim being synthesized. If treatment intensity and utilization outcomes are judged relevant enough to retain, the review should state this as a deliberate broadening of its own eligibility criteria rather than letting the discrepancy stand unremarked. A near-chance discriminatory study is folded into the narrative of concordant findings without qualification Santarelli et al. (2017a) reported no multivariable-adjusted estimate for bioelectrical impedance vector analysis and instead provided area-under-the-curve values of 0.56 at admission and 0.57 at discharge, with discrimination indistinguishable from chance alone [3]. This study is nonetheless grouped among those describing a “broadly concordant pattern” of elevated extracellular fluid indices predicting rehospitalization and mortality, alongside cohorts reporting genuinely independent adjusted hazard ratios above 1.9 [4]. Presenting a near-null discriminatory result and an adjusted hazard ratio of 2.67 as directionally equivalent contributions to the same body of evidence overstates how many of the 13 studies actually carry an independent prognostic signal once adjustment and discrimination are distinguished from simple directional concordance. A synthesis structured around adjusted effect estimates specifically, rather than the direction of association regardless of strength, would better isolate which cohorts carry real inferential weight. The same caution applies to Sakaguchi et al., where the reference equation for extracellular water was derived from a separate, non-heart failure control group rather than validated within the acute decompensated cohort itself, a methodological detail that affects how directly its hazard ratio can be compared with cohorts using manufacturer-validated equations. This review correctly separates the phase angle from fluid-specific indices and transparently reports where an association did not survive adjustment, a level of methodological candor that is uncommon in the literature. The clinical implication is direct: before BIA-derived congestion markers are described as consistently prognostic across 13 studies, the evidence base should be restated as a smaller set of cohorts that both report an adjusted estimate for a true clinical endpoint and clear a discrimination threshold meaningfully above chance. CRediT authorship contribution statement Lijiang Li: Visualization, Writing – original draft, Writing – review & editing. Bingjun Che: Conceptualization, Data curation, Formal analysis. Ethical approval Not applicable (commentary on previously published research). Declaration of Generative AI and AI-Assisted technologies in the writing process Generative AI tools were used solely for language refinement and formatting assistance. All scientific interpretation, critique, and conceptual analysis were independently developed by the authors. Funding None. Declaration of competing interest The authors declare no conflicts of interest. Acknowledgments None. Contributor Information Lijiang Li, Email: jiangjiang87li@163.com. Bingjun Che, Email: authorconnect@outlook.com. Data availability No new data were generated or analysed in this work. References Associated Data Data Availability Statement No new data were generated or analysed in this work.